Recent news on Depakene

Recall Of Two Valproic Acid Drugs, Depakene 500 Mg And Ratio ...  -  May 15, 2007
Medical News Today (press release),Health Canada is warning patients taking the anti-epilepsy medications Depakene 500 mg and ratio-VALPROIC 500 mg that they may not be getting the full dose

Health Canada/REMINDER/Warning: Recall of Two Valproic Acid Drugs ...  -  May 14, 2007
CCNMatthews (press release),These products are being recalled and patients using Depakene 500 mg and ratio-VALPROIC ECC 500 mg (valproic acid) are advised to contact their physician or

If you have these pills, take them back to your pharmacist  -  May 12, 2007
SooToday.comOTTAWA, ONTARIO - (May 11, 2007) - Health Canada is warning patients taking the anti-epilepsy medications Depakene 500 mg and ratio-Valproic 500 mg that

Health Canada recalls epilepsy medications  -  May 17, 2007
Waterloo Record,The department said in a release that the medications -- Depakene (sold in 500 milligram doses) and ratio-VALPROIC (also 500 milligrams) -- may not

Anti-epilepsy medications recalled  -  May 14, 2007
CBC Montreal,The recall applies to Depakene 500 mg, manufactured by Abbott Laboratories Ltd., and ratio-VALPROIC 500 mg, made by ratiopharm Inc.

Epilepsy Drug Lowers Children's IQ  -  May 4, 2007
Dog Flu Diet and Diseases,Valproate is one of the oldest epilepsy drugs on the market, and is also marketed under the brand names Depakote, Depakene, and Depacon.

AAN: In Utero Exposure to Valproate Lowers IQ  -  May 3, 2007
MedPage Today,BOSTON, May 3 -- Children whose mothers took valproate (Depakene) during pregnancy for control of epilepsy are at risk for significantly lower IQs than

Epilepsy Drug Linked to Low IQ  -  May 3, 2007
WebMDValproate -- sold under the brand names Depakote, Depakene, and Depacon -- is one of the oldest and most widely prescribed antiseizure medications on the

Research and Markets: New Report Analyzes Operations and Prospects ...  -  Apr 24, 2007
American Digital Networks (press release),R&D Projects BIW-8405 KW-0761 Growth Forecast CENTRAL NERVOUS SYSTEM Marketed Products Depakene Durotep Others R&D Projects Istradeylline Topiramate

Agitation in the Elderly  -  Feb 16, 2007
Psychiatric Times,The anticonvulsants, such as carbamazepine (Epitol, Tegretol) and valproate (Depakene, Depakote), appear to show promise in the management of the behavioral

... Go to the Article  -  Dec 1, 2006
CancerWiseThe MD Anderson study involves the drug decitabine (Dacogen®), which has been shown to be effective in the treatment of MDS, and valproic acid (Depakene®),

Valproic acid may help slow the progression of dementia  -  Dec 18, 2006
Xagena.it,Valproic acid ( Depakene ) is commonly used to prevent seizures in epilepsy patients. " This shows that a common, inexpensive drug gets into the brain,

In two minds  Sep 12, 2006
...severe mania or a mixed mood state, the first-line treatment is lithium or the anticonvulsant (antiepileptic) drug valproate (Depakote, Depakene), often adding ... -ITP.net

... Go to the Article  -  Dec 1, 2006
CancerWiseThe MD Anderson study involves the drug decitabine (Dacogen®), which has been shown to be effective in the treatment of MDS, and valproic acid (Depakene®),

Epilepsy drug poses high risk for fetal death and birth defects  Aug 23, 2006
A study, published in the journal Neurology, found that the epilepsy drug Valproate ( Depacon/Depakene/Depakote ) is associated with higher risk for fetal ... -Xagena.it

SC AG McMaster: 'Drug Companies Over-Charged Taxpayers'  Aug 4, 2006
Abbott companies and reimbursed by South Carolina Medicaid or the South Carolina State Health Plan include, but are not limited to, Depakene, Sodium Chloride ... -PharmaLive.com

Shingles and Chickenpox (Varicella-Zoster Virus)  Jun 23, 2006
Other anti-seizure medications used for PHN include carbamazepine (Tegretol), valproic acid (Depakene, Depakote), and phenytoin (Dilantin), although they are ... -About - News & Issues



Schuckit Addresses State-of-the-Art Addiction Treatments  May 14, 2006
Carbamaze-pine (Tegretol), valproic acid (Depakene) or gabapentin (Neurontin) are no better, they cost more and they are more dangerous than the benzodiazepines ... - Psychiatric Times

Kyowa Hakko Profits Decline on Higher R&D Spend but Recurring ...  Apr 27, 2006
Sales of Coniel, atreatment for hypertension and angina pectoris, and Depakene, anantiepileptic agent, were maintained at similar levels to thoserecorded in ... - Finanzen.net

Kyowa Hakko Profits Decline on Higher R&D Spend but Recurring ...  Apr 27, 2006
Sales of Coniel, a treatment for hypertension and angina pectoris, and Depakene, an antiepileptic agent, were maintained at similar levels to those recorded in ... - Genetic Engineering News



Kyowa Hakko Reports Good Progress Towards Full-Year Forecasts  Jan 30, 2006
Sales of Coniel, a treatment for hypertension and angina pectoris, and Depakene, an antiepileptic agent, were maintained at levels similar to those achieved in ... - Genetic Engineering News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional